Definitive Healthcare (NASDAQ:DH) Updates FY 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.320-0.340 for the period, compared to the consensus earnings per share estimate of 0.370. The company issued revenue guidance of $247.0 million-$251.0 million, compared to the consensus revenue estimate of $258.3 million. Definitive Healthcare also updated its FY24 guidance to $0.32-0.34 EPS.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on DH shares. Needham & Company LLC reaffirmed a hold rating on shares of Definitive Healthcare in a research note on Wednesday, May 8th. Stifel Nicolaus cut their price objective on Definitive Healthcare from $11.00 to $9.50 and set a buy rating on the stock in a research report on Wednesday, May 8th. Morgan Stanley cut Definitive Healthcare from an overweight rating to an equal weight rating and lowered their target price for the stock from $11.50 to $9.00 in a report on Wednesday, May 8th. Canaccord Genuity Group decreased their price objective on Definitive Healthcare from $10.00 to $8.00 and set a hold rating for the company in a research note on Wednesday, May 8th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on Definitive Healthcare from $10.00 to $7.00 and set a hold rating on the stock in a research report on Thursday, May 9th. Eight analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Definitive Healthcare has an average rating of Hold and an average target price of $9.56.

Definitive Healthcare Trading Down 3.9 %

Definitive Healthcare stock traded down $0.23 during trading on Tuesday, reaching $5.74. 3,696,056 shares of the company were exchanged, compared to its average volume of 710,079. Definitive Healthcare has a 52-week low of $4.38 and a 52-week high of $11.97. The company has a market capitalization of $676.92 million, a P/E ratio of -3.28, a PEG ratio of 4.36 and a beta of 1.30. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.30 and a quick ratio of 2.30. The stock’s 50 day simple moving average is $5.55 and its two-hundred day simple moving average is $7.17.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Tuesday, May 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.04). The firm had revenue of $63.48 million during the quarter, compared to analysts’ expectations of $64.00 million. Definitive Healthcare had a negative net margin of 78.16% and a positive return on equity of 0.51%. On average, equities research analysts expect that Definitive Healthcare will post 0.1 earnings per share for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.